Abstract
Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy despite several~decades of progress in diagnosis and treatment. Taking advantage of the robust development of discovery and utility of prognostic biomarkers, clinicians and researchers are developing personalized and targeted treatment strategies. This review encompasses recently discovered biomarkers of ovarian cancer, the utility of published prognostic biomarkers for EOC (especially biomarkers related to angiogenesis and key signaling pathways), and their integration into clinical practice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 231-251 |
| Number of pages | 21 |
| Journal | Cancer Biomarkers |
| Volume | 8 |
| Issue number | 4-5 |
| DOIs | |
| State | Published - 2010 |
Keywords
- Biomarkers
- ovarian carcinoma
- prognosis
ASJC Scopus subject areas
- Oncology
- Genetics
- Cancer Research